Sectors
RMD
ResMed Inc.
224.99
300 x 222.00
100 x 245.00
bid
ask
-
3.43
1.50%
200 @ 07:55 PM
224.99 +0.00 (0.00%)
| Ytd | -6.59% | |
| 1y | -17.67% |
224.56
day range
228.38
180.27
52 week range
284.87
| Open | 228.21 | Prev Close | 228.42 | Low | 224.56 | High | 228.38 | Mkt Cap | 32.46B |
| Vol | 3.82M | Avg Vol | 1.47M | EPS | 10.44 | P/E | 21.55 | Forward P/E | 17.00 |
| Beta | 0.77 | Short Ratio | 8.34 | Inst. Own | 71.23% | Dividend | 2.64 | Div Yield | 1.16 |
| Ex Div Date | 08-20 | Earning | 10-29 | 50-d Avg | 218.41 | 200-d Avg | 227.20 | 1yr Est | 246.44 |
| Income Statement | |||
| Total Revenue | 1.46B | ||
| Revenues (USD) | 1.46B | ||
| Cost of Revenue | 602.43M | ||
| Gross Profit | 861.22M | ||
| Operating Expenses | 412.51M | ||
| Research and Development Expense | 105.73M | ||
| Selling, General and Administrative Expense | 296.28M | ||
| Operating Income | 448.71M | ||
| Interest Expense | 29.03M | ||
| Income Tax Expense | 90.73M | ||
| Net Income | 383.43M | ||
| Net Income Common Stock | 383.43M | ||
| Net Income Common Stock (USD) | 383.43M | ||
| Consolidated Income | 383.43M | ||
| Earnings per Basic Share | 2.65 | ||
| Earnings per Basic Share (USD) | 2.65 | ||
| Earnings per Diluted Share | 2.64 | ||
| Dividends per Basic Common Share | 0.60 | ||
| Earning Before Interest & Taxes (EBIT) | 503.19M | ||
| Earning Before Interest & Taxes (USD) | 503.19M | ||
| Weighted Average Shares | 144.71M | ||
| Weighted Average Shares Diluted | 145.11M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.47B | ||
| Cash and Equivalents (USD) | 1.47B | ||
| Trade and Non-Trade Receivables | 1.04B | ||
| Current Assets | 4.32B | ||
| Property, Plant & Equipment Net | 735.00M | ||
| Total Assets | 8.97B | ||
| Debt Current | 289.09M | ||
| Total Debt | 825.92M | ||
| Current Liabilities | 1.40B | ||
| Debt Non-Current | 536.83M | ||
| Total Liabilities | 2.38B | ||
| Accumulated Retained Earnings (Deficit) | 7.26B | ||
| Accumulated Other Comprehensive Income | -82.51M | ||
| Shareholders Equity | 6.59B | ||
| Shareholders Equity (USD) | 6.59B | ||
| Assets Non-Current | 4.64B | ||
| Total Debt (USD) | 825.92M | ||
| Deferred Revenue | 333.86M | ||
| Goodwill and Intangible Assets | 3.36B | ||
| Inventory | 945.81M | ||
| Liabilities Non-Current | 985.45M | ||
| Trade and Non-Trade Payables | 308.92M | ||
| Tax Assets | 329.25M | ||
| Tax Liabilities | 162.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 55.12M | ||
| Net Cash Flow from Financing | -263.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -191.28M | ||
| Capital Expenditure | -51.13M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -325.32M | ||
| Issuance (Purchase) of Equity Shares | -170.69M | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Payment of Dividends & Other Cash Distributions | -87.09M | ||
| Net Cash Flow from Investing | -383.65M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.08M | ||
| Net Cash Flow from Operations | 454.63M | ||
| Effect of Exchange Rate Changes on Cash | 905.00K | ||
| Share Based Compensation | 27.46M | ||